tiprankstipranks

GB:0MT7 Price & Analysis

Compare

0MT7 ETF Chart & Stats

ETF Overview

Invesco STOXX Europe 600 Optimised Health Care UCITS ETF

The Invesco STOXX Europe 600 Optimised Health Care UCITS ETF, ticker GB:0MT7, offers investors a targeted approach to capitalizing on the robust potential of the European health care sector. This exchange-traded fund is meticulously designed to provide exposure to the STOXX Europe 600 Optimised Health Care Index, which comprises leading health care companies across the European continent. As a sector-focused ETF, it zeroes in on businesses ranging from pharmaceuticals and biotechnology to medical equipment and health care services, encapsulating a diverse array of industry segments within this vital sector. This ETF stands out by utilizing an optimized strategy that seeks to enhance returns while managing risks, making it an apt choice for investors seeking both growth and stability in their portfolios. The fund's broad-based yet niche approach allows investors to benefit from the dynamic innovation and advancements characteristic of the health care industry, which remains a cornerstone of economic development and societal well-being in Europe. With its UCITS (Undertakings for Collective Investment in Transferable Securities) framework, the Invesco STOXX Europe 600 Optimised Health Care UCITS ETF offers a high level of investor protection and regulatory oversight, ensuring transparency and confidence. Whether you are a seasoned investor or new to the market, this ETF provides a strategic entry point into Europe's burgeoning health care sector, combining potential capital appreciation with the ethical satisfaction of contributing to the advancement of health and medical sciences.

Invesco STOXX Europe 600 Optimised Health Care UCITS ETF (0MT7) Fund Flow Chart

Invesco STOXX Europe 600 Optimised Health Care UCITS ETF (0MT7) 1 year Net Flows: -€18M

0MT7 ETF FAQ

What was GB:0MT7’s price range in the past 12 months?
GB:0MT7 lowest ETF price was €366.20 and its highest was €426.81 in the past 12 months.
    What is the AUM of GB:0MT7?
    As of Feb 03, 2025 The AUM of GB:0MT7 is 7.77M.
      Is GB:0MT7 overvalued?
      According to Wall Street analysts GB:0MT7’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
        Does GB:0MT7 pay dividends?
        GB:0MT7 does not currently pay dividends.
        How many shares outstanding does GB:0MT7 have?
        Currently, no data Available
        Which hedge fund is a major shareholder of GB:0MT7?
        Currently, no hedge funds are holding shares in GB:0MT7

        Top 10 Holdings

        Name
        Weight %
        ROG
        Roche Holding
        10.36%
        AstraZeneca plc
        10.09%
        NOVN
        Novartis
        9.87%
        Sanofi
        9.43%
        NOVO.B
        Novo Nordisk A/S (UK)
        7.81%
        Essilorluxottica Sa
        6.52%
        GlaxoSmithKline plc (UK)
        5.71%
        LONN
        Lonza Group
        3.69%
        ALC
        Alcon
        3.06%
        Haleon PLC
        2.80%
        Total69.34%
        See All Holdings
        Popular ETFs
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis